JRJohanna G. I. van Rietschoten

Johanna G. I. van Rietschoten

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Johanna G. I. van Rietschoten has a total of 21 co-authors. Here are the top co-authors by number of shared publications:

  • A Van Veen

    1 shared publication
  • C C Cortez

    Department of Urology, Biochemistry and Molecular Biology, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA

    1 shared publication
  • C L Verweij

    Department of Pathology, VU University Medical Center (VUMC), Amsterdam, The Netherlands

    1 shared publication
  • Cor L. Verweij

    American Society for Biochemistry and Molecular Biology

    1 shared publication
  • E A Wierenga

    1 shared publication
  • E N Gal-Yam

    Department of Urology, Biochemistry and Molecular Biology, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA

    1 shared publication

Latest Publications

  • Epigenetic regulation and nucleosome positioning in the human TATA-less IL-1α promoter

    by J G I van Rietschoten, E N Gal-Yam, S Jeong, C C Cortez, C L Verweij, P A Jones

    Interleukin-1α (IL-1α) is secreted by a variety of cell types and is a major player in immune and inflammatory processes. Genes involved in immunological processes are known to be strictly regulated; however, how epigenetic mechanisms contribute to this regulation in not understood. To gain insight into the epigenetic regulation of the human TATA-less IL-1A gene, we show that active and silent chromatin modifications characterize the regulatory regions of IL-1α in expressing and non-expressing cells, respectively, and that the DNA methylation in the proximal promoter is associated with the expression status of the cells. Interestingly, although nucleosome depletion in active promoters is found in yeast and fly genes, now it has been reported in human promoters. We here show on the level of single DNA molecules that in expressing cells, a nucleosome is absent in about half of the proximal IL-1α promoters. This observation might reflect a more subtle regulation of nucleosome positioning in TATA-less genes or human genes in general.


  • Differentially methylated alleles in a distinct region of the human interleukin-1 promoter are associated with allele-specific expression of IL-1 in CD4+ T cells

    by Johanna G. I. van Rietschoten, Kitty F. Verzijlbergen, Sonja I. Gringhuis, Tineke C. T. M. van der Pouw Kraan, Jean-Pierre Bayley, Eddy A. Wierenga, Peter A. Jones, Jan M. Kooter, Cor L. Verweij

    Cytokine secretion profiles of activated T cells are critical for maintaining the immunologic balance between protection and tolerance. In mice, several cytokines have been reported to exhibit monoallelic expression. Previously, we found that the human interleukin-1 alpha (IL1A) gene exhibits a stable allele-specific expression pattern in CD4+ T-cell clones. We investigated whether DNA methylation is involved in the allele-specific expression of IL-1α. Here, we show that differential methylation of CpGs in the proximal promoter region is associated with allele-specific expression of IL-1α in CD4+ T cells. The differential methylation pattern is already observed in naive T cells. In keratinocytes, which constitutively produce IL-1α, the proximal promoter is hypomethylated. CpGs located further upstream and in intron 4 were almost all methylated, irrespective of expression. Treatment of nonexpressing cells and of T-cell clones with 5-aza-2′deoxycytidine induced IL-1α expression in the nonexpressing cells and induced expression of the formerly silent allele in T-cell clones. In addition, electrophoretic mobility shift assays showed that methylation of CpGs in the proximal promoter resulted in direct inhibition of binding of nuclear factor(s). Taken together, these results suggest that allele-specific expression of IL-1α in CD4+ cells is achieved, at least in part, by differential methylation of the promoter.


  • A novel polymorphic GATA site in the human IL‐12Rβ2 promoter region affects transcriptional activity

    by J G I Van Rietschoten, R Westland, R Van Den Bogaard, M A Nieste-Otter, A Van Veen, R E Jonkers, T C T M Van Der Pouw Kraan, M T Den Hartog, E A Wierenga

    Abstract:  Interleukin‐12 (IL‐12) is a potent inducer of interferon‐γ production by T cells and is a major factor for the development of T‐helper 1 (Th1) cells. It exerts its biological effects through binding to the IL‐12 receptor (IL‐12R), a heterodimer composed of a 1 and a β2 subunits. The signaling β2 chain is expressed on Th1 cells and to a lesser extent on Th0 cells, but not on Th2 cells, rendering these latter cells unresponsive to IL‐12. Polymorphisms in the coding region of the IL‐12Rβ2 gene were shown to be associated with atopic disease. Here, we analyzed the 5′‐regulatory region of the human IL‐12Rβ2 gene by denaturing high‐performance liquid chromatography (Transgenomic WAVE system, San Jose, CA). We found five novel single‐nucleotide polymorphisms (SNPs) in the proximal 1.2 kb IL‐12Rβ2 promoter region, i.e. −237C/T, −465A/G, −1023A/G, −1033T/C, and −1035A/G. SNP −465A/G is of particular interest as it determines the integrity of a GATA consensus site. By functional comparison of both −465 alleles in transient transfection assays, we show that promoter activity is increased in case of the −465G allele, disrupting the intact GATA site. Comparison of the prevalence of −465A/G SNP alleles in small cohorts of allergic asthmatic and healthy control individuals provided no evidence for an altered distribution in the asthmatic population. In conclusion, we have identified a novel polymorphic GATA site that may affect transciptional activity of the human IL‐12Rβ2 gene under GATA3‐mediated, Th2‐polarizing conditions.